aod9604 inhibits lipogenesis De Novo as a Source of Second Messengers in Adipocytes | Current Diabetes Reports AOD-9604 is the quiet powerhouse
Description
Therapeutic response to cyanocobalamin may decrease due to elderly age, infection, renal insufficiency, diabetes mellitus, marrow suppressants use (e.g
References: Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
2015 Jan "Vitamin B12 - Health Professional Fact Sheet"
These symptoms go off in a few weeks and wont disrupt long-term treatment
